19534 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 

address, company phone number, and email address. You will receive a 

confirmation within 2 business days. 

We also will accept walk-in 

registration at the meeting site, but 

space is limited, and we will close 

registration when maximum seating 

capacity (approximately 100) is reached. 

We will try to accommodate all 

persons who wish to make a 

presentation. The time allotted for 

presentations may depend on the 

number of persons who wish to speak. 

Additionally, regardless of whether 

you wish to make a presentation or 

simply attend the meeting, please notify 

us if you need any special 

accommodations (such as wheelchair 

access or a sign language interpreter). 

If you would like to submit comments 

regarding these proposed 

recommendations, please send your 

comments to the Division of Dockets 

Management (see ADDRESSES). Submit a 

single copy of electronic comments or 

two paper copies of any written 

comments, except that individuals may 

submit one paper copy. Comments are 

to be identified with the docket number 

found in brackets in the heading of this 

document. Received comments may be 

seen in the Division of Dockets 

Management between 9 a.m. and 4 p.m., 

Monday through Friday. Submit your 

comments no later than May 18, 2007. 

C. Will Meeting Transcripts Be 

Available? 

We will prepare a meeting transcript 

and make it available on our Web site 

(http://www.fda.gov) after the meeting. 

We anticipate that transcripts will be 

available approximately 30 working 

days after the meeting. The transcript 

will also be available for public 

examination at the Division of Dockets 

Management (HFA–305), 5630 Fishers 

Lane, rm. 1061, Rockville, MD 20857, 

between 9 a.m. and 4 p.m. Monday 

through Friday. 

Dated: April 12, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. 07–1919 Filed 4–16–07; 1:52 pm] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[FDA 225–07–4301] 

Memorandum of Understanding 

Between the National Cancer Institute 

and the Food and Drug Administration 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is providing 

notice of a memorandum of 

understanding (MOU) between FDA and 

the National Cancer Institute (NCI), part 

of the National Institutes of Health 

(NIH) of the Department of Health and 

Human Services (DHHS). The purpose 

of this MOU is to establish a formal 

collaboration between FDA and NCI 

regarding the creation of a common 

standards-based data repository to 

facilitate the electronic exchange and 

analysis of data from research studies on 

investigational drugs in a fully secure 

manner. 

DATES: The agreement became effective 

March 2, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Randy Levin, Center for Drug Evaluation 

Research (HF–18), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–7784 email: randy.levin@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 20.108(c), 

which states that all written agreements 

and MOUs between FDA and others 

shall be published in the Federal 

Register, the agency is publishing notice 

of this MOU. 

Dated: April 5, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

BILLING CODE 4160–01–S 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19535 


pwalker on PROD1PC71 with NOTICESEN18AP07.000</GPH>
19536 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 


pwalker on PROD1PC71 with NOTICESEN18AP07.001</GPH>
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19537 


pwalker on PROD1PC71 with NOTICESEN18AP07.002</GPH>
19538 Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 


pwalker on PROD1PC71 with NOTICESEN18AP07.003</GPH>
Federal Register / Vol. 72, No. 74 / Wednesday, April 18, 2007 / Notices 19539 

[FR Doc. 07–1921 Filed 4–17–07; 8:45 am] 

BILLING CODE 4160–01–C 


pwalker on PROD1PC71 with NOTICESEN18AP07.004</GPH>